Would you use a reduced dose glucocorticoid tapering regimen for patients with vasculitis due to Sjögren’s syndrome treated with Rituximab?
Patient with Sjögren’s with cutaneous vasculitis and mononeuritis multiplex. Received IV methylprednisolone and Rituximab. Now on oral steroids. Is it OK to use reduced dose glucocorticoid dosing (from vasculitis guidelines) if patient is improving?